中英科技 reported revenue of ¥0.14B for the period ended 2026-06-30, +48.7% year on year. Net income was ¥-0.00B, a -3.0% net margin on a 15.0% gross margin. The largest revenue line is 通信材料 at 64% of the total. Free cash flow for the period was ¥-0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.14B | +48.7% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.00B | — |
| Gross margin | 15.0% | Net margin -3.0% |
| Revenue Q/Q | +30.2% | — |
| Segment | Revenue | Share |
|---|---|---|
| 通信材料 | ¥0.09B | 64.4% |
| 半导体封装材料 | ¥0.04B | 27.6% |
| 其他 | ¥0.01B | 8.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.12B | 85.0% |
| R&D | ¥0.01B | 4.1% |
| SG&A | ¥0.02B | 15.7% |
| Tax & other | ¥-0.00B | -1.0% |
| Item | Amount |
|---|---|
| Total assets | ¥1.14B |
| Total liabilities | ¥0.14B |
| Shareholders' equity | ¥1.00B |
| Equity / assets | 88.0% |
| Operating cash flow | ¥-0.03B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.03B |
| Cash conversion (OCF / net income) | 1355% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
药易购 ・ 信测标准 ・ 秋田微 ・ 南极光 ・ 创识科技 ・ 易瑞生物 ・ 春晖智控 ・ 曼卡龙 ・ 恒而达 ・ 德必集团 ・ 冠中生态 ・ 奥雅股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies